Europe has money, human resources and a basic-science base that produces world-leading cancer research. Why, then, aren’t these assets being translated into clinical advances?
Translating good science into new treatments
Hannah Brown
Related Articles
Cover Story
José Baselga: playing to Europe’s strengths
Senza categoria
How Europe is taking on the big biobank challenge
Grandround